$NVAX just saw the interview with Economic Club. While Stan was tired, he was extremely confident about not just the data for covid but about nanoflu and rsv as well. Basically said the data is the best amongst all the players right now for covid and is pretty confident it will get approved. Also confident that the platform now works for vaccines. I am more bullish now than I ever was. Reason being this has gone from a vaccine play to a biotech play with a platform that scales. Tech gets valued at much higher multiples that pharma.
  • 15
15 Likes